CONNECT WITH US
Tech

Tech

The Brain-Eating Amoeba Kills 97% of Its Victims. Scientists May Have Found a Way to Stop It in Hours

Gizmodo - Tech logo

Published on

Add as a preferred source on Google
The Brain-Eating Amoeba Kills 97% of Its Victims. Scientists May Have Found a Way to Stop It in Hours

Naegleria fowleri, a.k.a. the brain-eating amoeba, can cause a rare, but nearly always fatal infection when it inadvertently enters people’s brains. Scientists at the University of California, San Diego, may have just found a new weapon that can stop the amoeba before it turns deadly.

In a study published earlier this week, UC San Diego researchers detailed their discovery of a compound isolated from marine bacteria that seems to be especially effective against N. fowleri. In lab tests so far, the compound appeared capable of killing various strains of the amoeba within hours while mostly sparing human cells. More work is needed to confirm its effectiveness and safety, the researchers say.

“Our findings identified a potent marine-derived compound and its potential target in N. fowleri,” they wrote in their paper, published Monday in the journal Marine Drugs.

N. fowleri is a shapeshifting amoeba that lives in soil and warm freshwater. It typically feeds on bacteria and isn’t dangerous to us when it’s simply ingested in water. When the amoeba enters our body through the nose, however, it can migrate to the brain. And once there, it can literally eat brain cells and spark massive inflammation, causing a severe infection called primary amebic meningoencephalitis, or PAM.

S. S. has gradually moved north. Studies have also shown that the amoeba is readily found in certain environments commonly visited by people, such as natural hot water springs at national parks.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.